What is the diagnosis and recommended treatment for a 64‑year‑old woman with a hematocrit of 35.8%, elevated red cell distribution width, low mean corpuscular hemoglobin, low mean corpuscular hemoglobin concentration, and mild monocytosis, eosinophilia, and basophilia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Iron Deficiency Anemia

This 64-year-old woman has iron deficiency anemia, characterized by microcytic hypochromic red cells (low MCH 22.9 pg, low MCHC 29.6 g/dL) with elevated RDW (18.2%), indicating a heterogeneous red cell population typical of iron deficiency. 1

Laboratory Interpretation

The combination of low MCV (implied by low MCH) with RDW >14.0% strongly indicates iron deficiency anemia rather than thalassemia, which typically presents with RDW ≤14.0%. 1, 2

  • MCH is more reliable than MCV for detecting iron deficiency because it is less dependent on storage conditions and counting equipment, and decreases in both absolute and functional iron deficiency. 1
  • The hematocrit of 35.8% represents moderate anemia in an adult woman (normal ≥36%). 3
  • The mild monocytosis (10.7%), eosinophilia (3.7%), and basophilia (1.8%) are nonspecific findings that do not alter the primary diagnosis. 1

Required Diagnostic Workup

Before initiating treatment, you must obtain serum ferritin and transferrin saturation to confirm iron deficiency and guide therapy. 1, 2

  • Serum ferritin <30 μg/L confirms iron deficiency in the absence of inflammation; ferritin <100 μg/L indicates iron deficiency when inflammation is present. 1
  • Transferrin saturation <16–20% confirms insufficient circulating iron for erythropoiesis. 1
  • Measure C-reactive protein (CRP) concurrently because ferritin is an acute-phase reactant that can be falsely elevated in inflammatory, infectious, malignant, or hepatic conditions. 2

Mandatory Investigation for Source of Iron Loss

In a 64-year-old woman with confirmed iron deficiency anemia, gastrointestinal evaluation is mandatory even if menstrual bleeding appears explanatory, because occult GI malignancy is a critical concern in this age group. 2

  • Both upper endoscopy with duodenal biopsies AND colonoscopy must be performed to exclude gastrointestinal malignancy, which is the most common cause of iron deficiency in post-menopausal women. 2
  • Upper endoscopy with duodenal biopsies is required to exclude celiac disease, which accounts for 2–3% of iron deficiency anemia cases. 1, 2
  • Colonoscopy is high-yield for detecting colonic carcinoma, adenomatous polyps, and angiodysplasia in older adults. 2
  • Heavy menstrual bleeding should be assessed if the patient is still menstruating, but this does not eliminate the need for GI evaluation. 2

Treatment Algorithm

Immediate Therapy

Initiate oral iron supplementation immediately while the diagnostic workup proceeds. 2

  • First-line treatment is ferrous sulfate 200 mg (65 mg elemental iron) three times daily for at least three months after correction of anemia to replenish iron stores. 2
  • Alternative formulations include ferrous gluconate or ferrous fumarate if ferrous sulfate is not tolerated; ascorbic acid can be added to enhance iron absorption. 2

Expected Response and Monitoring

  • A hemoglobin rise ≥10 g/L (≥1 g/dL) within 2 weeks confirms iron deficiency diagnosis. 1, 2
  • If the patient fails to respond to oral iron within 2–4 weeks, consider non-compliance, ongoing blood loss, malabsorption, or true intolerance to oral preparations. 2

Second-Line Therapy for Treatment Failure

If malabsorption is confirmed or oral iron is not tolerated, switch to intravenous iron (iron sucrose or iron gluconate) with an expected hemoglobin increase of at least 2 g/dL within 4 weeks. 1, 2, 4

  • Intravenous iron sucrose can be administered as 200 mg over 2–5 minutes five times within 14 days, or two 500 mg infusions on Day 1 and Day 14 over 3.5–4 hours. 4

Long-Term Monitoring

  • Monitor hemoglobin concentration and red cell indices at three-monthly intervals for one year, then after a further year. 2
  • Provide additional oral iron if hemoglobin or MCV falls below normal. 2

Critical Pitfalls to Avoid

  • Do not attribute iron deficiency anemia in a 64-year-old woman solely to inadequate dietary intake or menstrual loss; occult gastrointestinal blood loss from malignancy must be excluded. 2
  • Do not rely on ferritin alone when inflammation is present; add transferrin saturation to confirm iron deficiency. 1
  • Do not overlook combined deficiencies—iron deficiency may coexist with vitamin B12 or folate deficiency, suggested by elevated RDW with normal MCV. 1, 5
  • Do not assume all microcytic anemia is iron deficiency; if iron studies are normal, order hemoglobin electrophoresis to exclude thalassemia trait. 1, 2
  • Do not delay gastrointestinal investigation while treating with iron; both should proceed simultaneously. 2

References

Guideline

Causes of Low MCH and MCHC

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Microcytic Hypochromic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Abnormal Red Cell Distribution Width (RDW)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the next step in managing a patient with normal hemoglobin (Hgb) levels, high Red Cell Distribution Width (RDW), and low Mean Corpuscular Hemoglobin (MCH)?
Given a CBC showing white blood cell count 6.4 ×10³/µL (normal), red blood cell count 5.60 ×10⁶/µL (high), hemoglobin 13.3 g/dL (normal), hematocrit 43.8% (normal), mean corpuscular volume 78 fL (low), mean corpuscular hemoglobin 23.8 pg (low), mean corpuscular hemoglobin concentration 30.4 g/dL (low), and red cell distribution width 16.6% (high), what is the most likely diagnosis and what should be the next diagnostic step?
What is the appropriate treatment plan for a 66-year-old female patient with elevated Alkaline Phosphatase (ALP) and Red Cell Distribution Width (RDW), normal Hemoglobin (Hb), Hematocrit (Hct), and Red Blood Cell (RBC) count, and no clear diagnosis?
What are the causes of an elevated Red Cell Distribution Width (RDW) and a low Mean Corpuscular Hemoglobin (MCH)?
What is the most likely diagnosis for a patient with hemoglobin 13.3 g/dL, hematocrit 43.8 %, RBC count 5.60 ×10⁶/µL, MCV 78 fL, MCH 23.8 pg, MCHC 30.4 g/dL, RDW 16.6 % and how should this condition be evaluated and managed?
What are the recommended daily vitamin D (cholecalciferol) supplementation doses for all age groups, including infants, children, adults, pregnant or lactating women, and the elderly, and when are higher doses indicated?
How should I manage swelling and erythema at an intravenous (IV) site after an infusion?
What liver, muscle, renal, pregnancy, and drug‑interaction safety concerns and monitoring are required when prescribing Nexlizet (ezetimibe 10 mg/rosuvastatin)?
What are the indications, dosing regimens (including pediatric and renal adjustments), contraindications, and adverse effects of oseltamivir (Tamiflu) for treatment and prophylaxis of influenza?
Can hematuria cause leukocytes on urinalysis?
How should a bladder stone be diagnosed and managed, including size-based treatment options and preventive measures?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.